Corrigendum to “Aldehyde dehydrogenase 2 activation ameliorates cyclophosphamide-induced acute cardiotoxicity via detoxification of toxic aldehydes and suppression of cardiac cell death” [Journal of Molecular and Cellular Cardiology (JMCC) volume 121 (2018) 134–144]

The authors regret that the order of corresponding authors as listed in the original published version of this article was incorrect. Yuguo Chen should be the last author and the first corresponding author. The correct author list should be as follows: Wenwen Liu, Xiaoxuan Zhai, Wenjun Wang, Boyuan Zheng, Zhenxiao Zhang, Xinhui Fan, Jiali Wang*, Yuguo Chen*. Therefore, the information in the correspondence box should have been as follows: Correspondence to: Yuguo Chen and Jiali Wang, Qilu Hospital, Shandong University, No.107 Wenhuaxi Road, Jinan 250012, China E-mail addresses: [email protected] (Y. Chen), [email protected] (J. Wang) The authors would like to apologise for any inconvenience caused. Aldehyde dehydrogenase 2 activation ameliorates cyclophosphamide-induced acute cardiotoxicity via detoxification of toxic aldehydes and suppression of cardiac cell deathJournal of Molecular and Cellular CardiologyVol. 121PreviewCyclophosphamide (CY)-induced acute cardiotoxicity is a common side effect which is dose dependent. It is reported that up to 20% of patients received high dose of CY treatment suffered from acute cardiac dysfunction. However, the effective intervention strategies and related mechanisms are still largely unknown. We aimed to investigate the effects of aldehyde dehydrogenase 2 (ALDH2), an important endogenous cardioprotective enzyme, on CY-induced acute cardiotoxicity and the underlying mechanisms. Full-Text PDF